Johnson & Johnson Nanobiotix S.A. Transaction History
Johnson & Johnson
- $301 Million
- Q1 2025
A detailed history of Johnson & Johnson transactions in Nanobiotix S.A. stock. As of the latest transaction made, Johnson & Johnson holds 5,623,816 shares of NBTX stock, worth $21.1 Million. This represents 6.69% of its overall portfolio holdings.
Number of Shares
5,623,816
Previous 5,623,816
-0.0%
Holding current value
$21.1 Million
Previous $16.1 Million
24.74%
% of portfolio
6.69%
Previous 5.5%
Shares
2 transactions
Others Institutions Holding NBTX
# of Institutions
13Shares Held
6MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY239KShares$898,6700.0% of portfolio
-
Perceptive Advisors LLC New York, NY105KShares$394,9990.02% of portfolio
-
Jane Street Group, LLC New York, NY11.4KShares$42,8150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA10.2KShares$38,2910.0% of portfolio
-
Morgan Stanley New York, NY6.1KShares$22,9360.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $131M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...